Rogasi PG et al. |
Radioimmunoassay of thromboxane B2 in plasma: methodological modifications. |
1988 |
Thromb. Res. |
pmid:3175991
|
Schorer AE |
Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody. |
1997 |
Thromb. Res. |
pmid:9062953
|
Weide I and Simmet T |
Leukotriene formation by peripheral monocytes in contact-activated human blood. |
1993 |
Thromb. Res. |
pmid:8211886
|
Saldeen P et al. |
Increased synthesis of thromboxane B2 and 6-keto-PGF1 alpha in hand veins from patients with deep venous thrombosis. |
1983 |
Thromb. Res. |
pmid:6658723
|
Butler KD et al. |
Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben. |
1987 |
Thromb. Res. |
pmid:3109067
|
Watanabe T et al. |
Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. |
2001 |
Thromb. Res. |
pmid:11672751
|
Carroll RC et al. |
Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. |
2010 |
Thromb. Res. |
pmid:19962724
|
Ziegler BK et al. |
Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. |
2001 |
Thromb. Res. |
pmid:11672759
|
Ersöz G et al. |
The effect of submaximal exercise on platelet aggregation during late follicular and midluteal phases in women. |
2002 |
Thromb. Res. |
pmid:12590951
|
Mikashima H and Muramoto Y |
Protective effect of Y-20811, a long-lasting thromboxane synthetase inhibitor, on endotoxin shock in rabbits. |
1990 |
Thromb. Res. |
pmid:2326771
|
Agren JJ et al. |
Dose responses in platelet fatty acid composition, aggregation and prostanoid metabolism during moderate freshwater fish diet. |
1990 |
Thromb. Res. |
pmid:2326774
|
Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Winter M et al. |
Synthesis of thromboxane B2 in uraemia and the effects of dialysis. |
1983 |
Thromb. Res. |
pmid:6868024
|
Ersöz G et al. |
Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. |
2003 |
Thromb. Res. |
pmid:14698654
|
Addonizio VP et al. |
Inhibition of human platelet function by verapamil. |
1982 |
Thromb. Res. |
pmid:7164035
|
Vargaftig BB et al. |
Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. |
1982 |
Thromb. Res. |
pmid:7164036
|
Grauso F et al. |
Effects of iloprost (ZK 36374), a prostacyclin derivative, on platelet function after ischaemic exercise in patients with stable angina pectoris. |
1987 |
Thromb. Res. |
pmid:2447664
|
Vlodavsky I et al. |
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. |
1982 |
Thromb. Res. |
pmid:7179215
|
Udvardy M et al. |
Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. |
1987 |
Thromb. Res. |
pmid:3116717
|
GarcÃa Frade LJ et al. |
Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. |
1987 |
Thromb. Res. |
pmid:3118498
|
Carter AJ et al. |
Human pulmonary vessels obtained from necropsy produce less prostacyclin and thromboxane than fresh vessels obtained from operations. |
1984 |
Thromb. Res. |
pmid:6547546
|
Ditter H et al. |
Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin. |
1983 |
Thromb. Res. |
pmid:6197766
|
Navran SS et al. |
Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C. |
1984 |
Thromb. Res. |
pmid:6372157
|
Ishikawa Y et al. |
Effect of cytoplasmic pH on platelet activation by arachidonic acid. |
1989 |
Thromb. Res. |
pmid:2499076
|
Dalli E et al. |
Effects of hawthorn (Crataegus laevigata) on platelet aggregation in healthy volunteers. |
2011 |
Thromb. Res. |
pmid:21737127
|
Toivanen J et al. |
Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro. |
1985 |
Thromb. Res. |
pmid:3920778
|
Ishii H et al. |
The effect of plasma on platelet function in hypercholesterolemic rabbits and the changes in fatty acid composition of the plasma. |
1984 |
Thromb. Res. |
pmid:6234679
|
Stegmeier K et al. |
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug. |
1984 |
Thromb. Res. |
pmid:6385334
|
Mercer JB et al. |
The effect of short-term cold exposure on risk factors for cardiovascular disease. |
1999 |
Thromb. Res. |
pmid:10418798
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Hall ER et al. |
The reduction of platelet thrombi on damaged vessel wall by a thromboxane synthetase inhibitor in rabbits. |
1982 |
Thromb. Res. |
pmid:6891109
|
Gerrard JM et al. |
Studies in patients with bleeding disorders show that platelet-vessel interaction is important for thromboxane formation in bleeding time wounds. |
1990 |
Thromb. Res. |
pmid:2278038
|
Di Minno G et al. |
Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides. |
1982 |
Thromb. Res. |
pmid:6803385
|
Suehiro A et al. |
The role of platelet hyperfunction in thrombus formation in hyperlipidemia. |
1982 |
Thromb. Res. |
pmid:6803387
|
Wang JP et al. |
Antiplatelet effect of capsaicin. |
1984 |
Thromb. Res. |
pmid:6528310
|
Weide I et al. |
Effects of cyclooxygenase inhibitors on ex vivo cysteinyl-leukotriene production by whole human blood allowed to clot spontaneously. Comparison to stimulated blood. |
1992 |
Thromb. Res. |
pmid:1440511
|
Lin CH et al. |
HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets. |
1992 |
Thromb. Res. |
pmid:1412184
|
Tindall H et al. |
Thrombin generation precedes platelet activation in native blood taken from the hand during multiple blood sampling following cold challenge. |
1987 |
Thromb. Res. |
pmid:3617016
|
Deckmyn H et al. |
Prostacyclin production by whole blood from children: impairment in the hemolytic uremic syndrome and excessive formation in chronic renal failure. |
1983 |
Thromb. Res. |
pmid:6344317
|
Mannucci L et al. |
Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk. |
1987 |
Thromb. Res. |
pmid:3445229
|
Nosál' R et al. |
Chloroquine: a multipotent inhibitor of human platelets in vitro. |
2000 |
Thromb. Res. |
pmid:10828481
|
Chakroun T et al. |
Screening for aspirin resistance in stable coronary artery patients by three different tests. |
2007 |
Thromb. Res. |
pmid:17553552
|
Simmet T and Luck W |
Clotting of whole human blood induces cysteinyl-leukotriene formation. |
1989 |
Thromb. Res. |
pmid:2549655
|
Buchanan MR et al. |
The sex-related differences in aspirin pharmacokinetics in rabbits and man and its relationship to antiplatelet effects. |
1983 |
Thromb. Res. |
pmid:6221436
|
Randall MJ and Wilding RI |
Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01). |
1982 |
Thromb. Res. |
pmid:6897751
|
Di Minno G and Violi F |
Aspirin resistance and diabetic angiopathy: back to the future. |
2004 |
Thromb. Res. |
pmid:15115664
|
Vesterqvist O et al. |
Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans. |
1984 |
Thromb. Res. |
pmid:6695361
|
Best LC et al. |
Mode of action of dipyridamole on human platelets. |
1979 |
Thromb. Res. |
pmid:229583
|
Zijlstra FJ et al. |
Thrombotic thrombocytopenic purpura and plasma thromboxane B2 levels. |
1983 |
Thromb. Res. |
pmid:6684333
|
Altman R and Scazziota A |
Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. |
1986 |
Thromb. Res. |
pmid:3088757
|
Kudolo GB et al. |
Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. |
2002 |
Thromb. Res. |
pmid:12590952
|
Maderna P et al. |
Differential effects of oral administrations to human volunteers of acetylsalicylic acid, sodium salicylate and indomethacin on 12-hydroxyeicosatetraenoic acid formation by stimulated platelets. |
1988 |
Thromb. Res. |
pmid:3194896
|
Todd MK et al. |
Effect of exercise intensity on 6-keto-PGF1 alpha, TXB2, and 6-keto-PGF1 alpha/TXB2 ratios. |
1992 |
Thromb. Res. |
pmid:1615492
|
|
Platelet function during long-term treatment with ketanserin of claudicating patients with peripheral atherosclerosis. A multi-center, double-blind, placebo-controlled trial. The PACK Trial Group. |
1989 |
Thromb. Res. |
pmid:2528841
|
Pattison A et al. |
The in vitro effect of amrinone on thromboxane B2 synthesis in human whole blood. |
1986 |
Thromb. Res. |
pmid:3755259
|
Maguire ED and Wallis RB |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat. |
1983 |
Thromb. Res. |
pmid:6689221
|
Hashimoto Y et al. |
Characteristics of protein kinase C-independent exocytosis in human platelets. |
1997 |
Thromb. Res. |
pmid:9336873
|
Yue TL et al. |
Pharmacological profile of G619, a new platelet aggregation inhibitor. |
1992 |
Thromb. Res. |
pmid:1412200
|
Russell NH et al. |
Platelet adenine nucleotides and arachidonic acid metabolism in the myeloproliferative disorders. |
1981 |
Thromb. Res. |
pmid:6794179
|
Dupin JP et al. |
In vitro antiaggregant activity of paracetamol and derivatives. |
1988 |
Thromb. Res. |
pmid:3134743
|
Martin JF et al. |
The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. |
1983 |
Thromb. Res. |
pmid:6658722
|
Serebruany VL and Gurbel PA |
Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study. |
1999 |
Thromb. Res. |
pmid:10030832
|
Weide I et al. |
Intravascular cysteinyl-leukotriene formation by clotting whole human blood. Evidence from clamped umbilical vein segments and thrombus specimens. |
1993 |
Thromb. Res. |
pmid:8122190
|
Grimm LJ et al. |
Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation. |
1981 |
Thromb. Res. |
pmid:6801806
|
Uyama O et al. |
Plasma concentrations of 6-keto-prostaglandin F1 alpha in patients with hypertension, cerebrovascular disease or Takayasu's arteritis. |
1982 Jan 1-15 |
Thromb. Res. |
pmid:6121391
|
Voss R et al. |
In vitro and ex vivo effects of aspirin in patients on a low-dose aspirin therapy. |
1993 |
Thromb. Res. |
pmid:8122187
|
Hashizume T et al. |
Vinblastine inhibits platelet aggregation by a microtubule-independent mechanism, probably by its perturbing action on the plasma membrane. |
1988 |
Thromb. Res. |
pmid:3135636
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Teng CM et al. |
Antiplatelet actions of some coumarin compounds isolated from plant sources. |
1992 |
Thromb. Res. |
pmid:1523611
|
Hofmann D et al. |
Evidence for sustained platelet activation in patients with early postinfarction angina. |
1993 |
Thromb. Res. |
pmid:8303651
|
Korth R et al. |
Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes. |
1986 |
Thromb. Res. |
pmid:3961742
|
Knapp HR et al. |
Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men. |
1988 |
Thromb. Res. |
pmid:3293263
|
Sinzinger H et al. |
Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low-dose aspirin (ASA) in healthy volunteers. |
1989 |
Thromb. Res. |
pmid:2497545
|
Pinto S et al. |
No signs of increased thrombin generation in menopause. |
1990 |
Thromb. Res. |
pmid:2201101
|
Randall MJ et al. |
UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. |
1981 Jul 1-15 |
Thromb. Res. |
pmid:6795753
|
De Caterina R et al. |
Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. |
1985 |
Thromb. Res. |
pmid:3975876
|
Worthington RE and Fuller GC |
Dibutyryl cyclic guanosine monophosphate elevates bovine endothelial cell thromboxane production without affecting prostacyclin metabolism. |
1984 |
Thromb. Res. |
pmid:6322377
|
Teng CM et al. |
Platelet aggregation induced by equinatoxin. |
1988 |
Thromb. Res. |
pmid:2906181
|
Selley ML et al. |
The effect of cholesterol oxidation products on human platelet aggregation. |
1996 |
Thromb. Res. |
pmid:8885139
|
Kritz H et al. |
Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished. |
1995 |
Thromb. Res. |
pmid:8610276
|
Armstrong RA et al. |
No effect of dietary trans isomers of alpha-linolenic acid on platelet aggregation and haemostatic factors in european healthy men. The TRANSLinE study. |
2000 |
Thromb. Res. |
pmid:11108899
|
Kelton JG et al. |
Sex-related differences in the efficacy of acetylsalicylic acid (ASA) : the absorption of ASA and its effect on collagen-induced thromboxane B2 generation. |
1981 Oct 1-15 |
Thromb. Res. |
pmid:7330835
|
Ding YA et al. |
Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound. |
1995 |
Thromb. Res. |
pmid:7740521
|
Shatoor AS et al. |
Effect of Hawthorn (Crataegus aronia syn. Azarolus (L)) on platelet function in albino Wistar rats. |
2012 |
Thromb. Res. |
pmid:22261477
|
Prosdocimi M et al. |
Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery. |
1985 |
Thromb. Res. |
pmid:3840290
|
Driss F et al. |
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. |
1984 |
Thromb. Res. |
pmid:6098051
|
Carter AJ and Jones EW |
The effect of the degree of diabetic control on thromboxane synthesis in clotted whole blood. |
1986 |
Thromb. Res. |
pmid:3515613
|
Mogensen F et al. |
Effect of specific thromboxane-synthetase inhibition on thromboxane and prostaglandin synthesis in stable angina induced by exercise test. |
1985 |
Thromb. Res. |
pmid:4038824
|
Tzeng SH et al. |
Inhibition of platelet aggregation by some flavonoids. |
1991 |
Thromb. Res. |
pmid:1776142
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Neiman J et al. |
Platelet uptake of serotonin (5-HT) during ethanol withdrawal in male alcoholics. |
1987 |
Thromb. Res. |
pmid:2820078
|
Zahavi M et al. |
Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide. |
1990 |
Thromb. Res. |
pmid:2146767
|
Simmet T and Weide I |
Thromboxane and cysteinyl-leukotriene formation are differentially activated in spontaneously clotting whole human blood in vitro. |
1991 |
Thromb. Res. |
pmid:1866709
|
Weigel G et al. |
Regulation of eicosanoid release in human umbilical endothelial cells. |
1991 |
Thromb. Res. |
pmid:1656543
|
Ko FN et al. |
Antiplatelet effects of protopine isolated from Corydalis tubers. |
1989 |
Thromb. Res. |
pmid:2559491
|
Ito T et al. |
Role of activated platelets in endotoxin-induced DIC in rats. |
1990 |
Thromb. Res. |
pmid:2080492
|
Lukaszyk A et al. |
Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175). |
1992 |
Thromb. Res. |
pmid:1579898
|
Meyers KM et al. |
An evaluation of the arachidonate pathway of platelets from companion and food-producing animals, mink, and man. |
1980 |
Thromb. Res. |
pmid:7209869
|
Barbieri B et al. |
p-Aminobenzoic acid, but not its metabolite p-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner. |
1997 |
Thromb. Res. |
pmid:9175234
|